. 2011 Nov 28;33(1):66–74. doi: 10.1038/aps.2011.136

Table 3. Values of BMD and microstructural parameters after genistein treatment. Means±SEM. ^bP<0.05, ^cP<0.01 vs control group. ^eP<0.05, ^fP<0.01 vs low dose (10 mg/kg) genistein-treatment groups.

Parameters	Control group	Genistein (10 mg/kg)	Genistein (50 mg/kg)
BMD (mg/mm³)	761.273±38.076	887.893±31.714^b	993.276±47.386^ce
BMC (mg)	0.097±0.004	0.111±0.007^b	0.124±0.008^c
Bone volume (mm³)	0.079±0.002	0.089±0.005^c	0.093±0.004^c
BV/TV (%)	61.297±1.903	67.228±2.578^b	73.568±1.782^cf
Tb.Th (μm)	61.748±1.444	72.794±1.999^c	77.593±7.111^c
BS/BV (%)	31.993±1.184	27.806±1.325^c	25.923±2.112^c
Tb.N (#/mm³)	10.170±0.296	9.182±0.611^b	9.088±0.525^b
Tb.Sp (μm)	0.102±3.654	31.204±1.504^c	28.176±1.850^ce

BMD, bone mineral density; BMC, bone mineral content; BV/TV, trabecular bone volume fraction; BS/BV, bone surface-to-volume ratio; Tb.Th, mean trabecular thickness; Tb.N, trabecular number; Tb.Sp, mean trabecular separation; BV, bone volume.

Table 3. Values of BMD and microstructural parameters after genistein treatment. Means±SEM. bP<0.05, cP<0.01 vs control group. eP<0.05, fP<0.01 vs low dose (10 mg/kg) genistein-treatment groups.

Table 3. Values of BMD and microstructural parameters after genistein treatment. Means±SEM. ^bP<0.05, ^cP<0.01 vs control group. ^eP<0.05, ^fP<0.01 vs low dose (10 mg/kg) genistein-treatment groups.